📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Development of Pyrazolo[3,4-d]pyrimidine Kinase Inhibitors as Potential Clinical Candidates for Glioblastoma Multiforme. (2020)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acsmedchemlett.9b00530

PubMed Identifier: 32435367

Publication URI: http://europepmc.org/abstract/MED/32435367

Type: Journal Article/Review

Volume: 11

Parent Publication: ACS medicinal chemistry letters

Issue: 5

ISSN: 1948-5875